Reported Q: Q3 2024 Rev YoY: -5.6% EPS YoY: +155.3% Move: +0.82%
Agilent Technologies Inc
A
$115.48 0.82%
Exchange NYSE Sector Healthcare Industry Medical Diagnostics Research
Q3 2024
Published: Aug 30, 2024

Company Status Snapshot

Fast view of the latest quarter outcome for A

Reported

Report Date

Aug 30, 2024

Quarter Q3 2024

Revenue

1.58B

YoY: -5.6%

EPS

0.97

YoY: +155.3%

Market Move

+0.82%

Previous quarter: N/A

Follow this company to get upcoming quarter alerts automatically.

Earnings Highlights

  • Revenue of $1.58B down 5.6% year-over-year
  • EPS of $0.97 increased by 155.3% from previous year
  • Gross margin of 54.2%
  • Net income of 282.00M
  • ""We're investing in our digital ecosystem to further enhance our differentiated customer experience."" - Padraig McDonnell
A
Agilent Technologies Inc

Swipe to view all report sections

Executive Summary

Agilent Technologies Inc reported third-quarter 2024 revenues of $1.578 billion, reflecting a decline of 4.4% on a core basis, yet a 300 basis point improvement from Q2 2024. The operating margin improved to 27.4% as a result of enhanced cost efficiency measures aimed at achieving $100 million in annualized savings. Adjusted earnings per share (EPS) came in at $1.32, exceeding guidance by $0.04. In a challenging operating environment, Agilent has witnessed solid growth in services and consumables, with management expressing optimism regarding the acceleration of demand in upcoming quarters. Key growth vectors include the biopharma sector and sustainable solutions, underpinned by recent acquisitions which strengthen Agilent’s digital ecosystem and product offerings.

Key Performance Indicators

Revenue
Decreasing
1.58B
QoQ: 0.32% | YoY: -5.62%
Gross Profit
Increasing
855.00M
54.18% margin
QoQ: -0.12% | YoY: 29.94%
Operating Income
Increasing
333.00M
QoQ: -8.26% | YoY: 150.38%
Net Income
Increasing
282.00M
QoQ: -8.44% | YoY: 154.05%
EPS
Increasing
0.97
QoQ: -7.62% | YoY: 155.26%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q4 2025 1,861.00 1.53 +9.4% View
Q3 2025 1,738.00 1.18 +10.1% View
Q2 2025 1,668.00 0.75 +6.0% View
Q1 2025 1,681.00 1.11 +1.4% View
Q4 2024 1,701.00 1.21 +0.8% View
Q3 2024 1,578.00 0.97 -5.6% View